Rita Mehta
Rita Mehta
Associate clinical Professor
Verified email at
Cited by
Cited by
Endocrine therapy for hormone receptor-positive metastatic breast cancer: American Society of Clinical Oncology Guideline
HS Rugo, RB Rumble, E Macrae, DL Barton, HK Connolly, MN Dickler, ...
Journal of Clinical Oncology 34 (25), 3069-3103, 2016
Bevacizumab added to neoadjuvant chemotherapy for breast cancer
HD Bear, G Tang, P Rastogi, CE Geyer Jr, A Robidoux, JN Atkins, ...
New England Journal of Medicine 366 (4), 310-320, 2012
HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
A Gennari, MP Sormani, P Pronzato, M Puntoni, M Colozza, U Pfeffer, ...
JNCI: Journal of the National Cancer Institute 100 (1), 14-20, 2008
Combination anastrozole and fulvestrant in metastatic breast cancer
RS Mehta, WE Barlow, KS Albain, TA Vandenberg, SR Dakhil, ...
New England Journal of Medicine 367 (5), 435-444, 2012
Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy
A Cerussi, D Hsiang, N Shah, R Mehta, A Durkin, J Butler, BJ Tromberg
Proceedings of the National Academy of Sciences 104 (10), 4014-4019, 2007
Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy
BJ Tromberg, A Cerussi, N Shah, M Compton, A Durkin, D Hsiang, ...
Breast Cancer Research 7, 1-7, 2005
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy
JH Chen, B Feig, G Agrawal, H Yu, PM Carpenter, RS Mehta, O Nalcioglu, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2008
Diffuse optical monitoring of blood flow<? xpp qa?> and oxygenation in human breast cancer during<? xpp qa?> early stages of neoadjuvant chemotherapy
C Zhou, R Choe, N Shah, T Durduran, G Yu, A Durkin, D Hsiang, R Mehta, ...
Journal of biomedical optics 12 (5), 051903-051903-11, 2007
Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment
D Roblyer, S Ueda, A Cerussi, W Tanamai, A Durkin, R Mehta, D Hsiang, ...
Proceedings of the National Academy of Sciences 108 (35), 14626-14631, 2011
Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative 1H MR Spectroscopy1
HM Baek, JH Chen, K Nie, HJ Yu, S Bahri, RS Mehta, O Nalcioglu, MY Su
Radiology 251 (3), 653-662, 2009
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial
HD Bear, G Tang, P Rastogi, CE Geyer, Q Liu, A Robidoux, L Baez-Diaz, ...
The lancet oncology 16 (9), 1037-1048, 2015
Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy
AE Cerussi, VW Tanamai, D Hsiang, J Butler, RS Mehta, BJ Tromberg
Philosophical transactions of the royal society A: mathematical, physical …, 2011
Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy
S Ueda, D Roblyer, A Cerussi, A Durkin, A Leproux, Y Santoro, S Xu, ...
Cancer research 72 (17), 4318-4328, 2012
Predicting responses to neoadjuvant chemotherapy in breast cancer: ACRIN 6691 trial of diffuse optical spectroscopic imaging
BJ Tromberg, Z Zhang, A Leproux, TD O'Sullivan, AE Cerussi, ...
Cancer research 76 (20), 5933-5944, 2016
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the …
JA Zell, WY Tsang, TH Taylor, RS Mehta, H Anton-Culver
Breast Cancer Research 11, 1-10, 2009
Overall survival with fulvestrant plus anastrozole in metastatic breast cancer
RS Mehta, WE Barlow, KS Albain, TA Vandenberg, SR Dakhil, ...
New England Journal of Medicine 380 (13), 1226-1234, 2019
Independent association of angiogenesis index with outcome in prostate cancer
R Mehta, A Kyshtoobayeva, T Kurosaki, EJ Small, H Kim, R Stroup, ...
Clinical cancer research 7 (1), 81-88, 2001
The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature
JF Reavey-Cantwell, RI Haroun, M Zahurak, RE Clatterbuck, RJ Parker, ...
Journal of neuro-oncology 55, 195-204, 2001
Quantification of Choline-containing Compounds in Malignant Breast Tumors by 1H MR Spectroscopy Using Water as an Internal Reference at 1.5 T
HM Baik, MY Su, H Yu, O Nalcioglu, R Mehta
Magnetic Resonance Materials in Physics, Biology and Medicine 19, 96-104, 2006
Association between in vitro platinum resistance in the EDR assay and clinical outcomes for ovarian cancer patients
RW Holloway, RS Mehta, NJ Finkler, KT Li, CE McLaren, RJ Parker, ...
Gynecologic oncology 87 (1), 8-16, 2002
The system can't perform the operation now. Try again later.
Articles 1–20